a comprehensive study of vesicular and non vesicular mirnas from a volume of cerebrospinal fluid compatible with clinical practice
0301 basic medicine
microrna
diagnosis
Exosomes
Real-Time Polymerase Chain Reaction
CSF exosomes; CSF miRNAs; clinical samples; infants; microRNA profiling
differential expression
Central Nervous System Neoplasms
CSF miRNAs
Extracellular Vesicles
03 medical and health sciences
exosome
Humans
visualization
disease
0303 health sciences
infants
Sequence Analysis, RNA
clinical samples traumatic brain-injury
microRNA profiling
glioblastoma
Infant, Newborn
Infant
Reproducibility of Results
3. Good health
MicroRNAs
CSF exosomes
biomarker
extracellular vesicles
Research Paper
DOI:
10.5281/zenodo.3605969
Publication Date:
2019-01-01
AUTHORS (13)
ABSTRACT
Cerebrospinal fluid (CSF) microRNAs (miRNAs) have emerged as potential biomarkers for minimally invasive diagnosis of central nervous system malignancies. However, despite significant advances in recent years, this field still suffers from poor data reproducibility. This is especially true in cases of infants, considered a new subject group. Implementing efficient methods to study miRNAs from clinically realistic CSF volumes is necessary for the identification of new biomarkers. Methods: We compared six protocols for characterizing miRNAs, using 200-µL CSF from infants (aged 0-7). Four of the methods employed extracellular vesicle (EV) enrichment step and the other two obtained the miRNAs directly from cleared CSF. The efficiency of each method was assessed using real-time PCR and small RNA sequencing. We also determined the distribution of miRNAs among different CSF shuttles, using size-exclusion chromatography. Results: We identified 281 CSF miRNAs from infants. We demonstrated that the miRNAs could be efficiently detected using only 200 µL of biofluid in case of at least two of the six methods. In the exosomal fraction, we found 12 miRNAs that might be involved in neurodevelopment. Conclusion: The Norgen and Invitrogen protocols appear suitable for the analysis of a large number of miRNAs using small CSF samples.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES ()
CITATIONS ()
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....